Skip to main content

Diastology on echocardiography

 

Diastology on echocardiography refers to the assessment of left ventricular (LV) filling, relaxation, compliance, and filling pressures. It is a core component of modern echo practice because many patients with heart failure, hypertension, diabetes, ischemia, or valvular disease have preserved systolic function but significant diastolic dysfunction.



---


Why Diastolic Assessment Matters


• Explains symptoms in patients with normal ejection fraction

• Essential for diagnosing HFpEF

• Reflects myocardial ischemia, fibrosis, and hypertrophy earlier than systolic indices

• Guides prognosis and management


Diastolic dysfunction often precedes systolic dysfunction.



---


Physiology of Diastole (Echo Perspective)


Diastole has four functional phases:


1. Isovolumic relaxation



2. Early rapid filling



3. Diastasis



4. Atrial contraction




Echo parameters are designed to interrogate these phases.



---


Core Echocardiographic Parameters in Diastology


1. Mitral Inflow Doppler


Measured using pulsed-wave Doppler at the mitral leaflet tips.


Key components: • E wave – early diastolic filling

• A wave – atrial contraction

• E/A ratio

• Deceleration time (DT)

• Isovolumic relaxation time (IVRT)


Interpretation: • Reduced E, E/A < 0.8 → impaired relaxation

• E/A 0.8–2 → indeterminate or pseudonormal

• E/A ≥ 2 → restrictive filling



---


2. Tissue Doppler Imaging (TDI)


Sampled at septal and lateral mitral annulus.


Key parameter: • e′ velocity (septal and lateral)


Significance: • Reflects myocardial relaxation

• Less preload dependent than transmitral inflow


Normal values (approximate): • Septal e′ ≥ 7 cm/s

• Lateral e′ ≥ 10 cm/s



---


3. E/e′ Ratio


Calculated using mitral E wave divided by average e′.


Clinical relevance: • Surrogate for LV filling pressures


Interpretation: • E/e′ < 8 → normal filling pressure

• E/e′ 9–14 → indeterminate

• E/e′ > 14 → elevated filling pressure



---


4. Left Atrial Volume Index (LAVI)


Represents chronic exposure to elevated LV filling pressures.


Normal: • ≤ 34 ml/m²


Enlarged LA strongly supports chronic diastolic dysfunction.



---


5. Pulmonary Vein Doppler


Provides complementary information on LA pressure and compliance.


Key waves: • S wave (systolic)

• D wave (diastolic)

• Ar wave (atrial reversal)


Findings: • Blunted S wave, prominent D wave → elevated LA pressure



---


Grading of Diastolic Dysfunction (ASE-Based Approach)


Grade I – Impaired Relaxation


• E/A < 0.8

• Normal filling pressures

• Common in aging, mild LVH


Grade II – Pseudonormal


• E/A appears normal (0.8–2)

• Elevated filling pressures

• Requires TDI, E/e′, LAVI for diagnosis


Grade III – Restrictive Filling


• E/A ≥ 2

• Short DT

• Markedly elevated filling pressures

• Poor prognosis



---


Diastology in Special Clinical Settings


Heart Failure with Preserved EF (HFpEF)


• Diastolic dysfunction is the hallmark

• Elevated E/e′, enlarged LA, high TR velocity support diagnosis


Hypertension and LVH


• Early impaired relaxation

• Progresses to pseudonormal filling


Ischemia


• Diastolic abnormalities appear before systolic changes

• Reduced e′ is an early marker


Atrial Fibrillation


• No A wave

• Reliance on E/e′, TR velocity, LA size



---


Common Pitfalls in Diastolic Assessment


• Age-related changes mimicking pathology

• Load dependence of Doppler parameters

• Mitral valve disease affecting inflow patterns

• Poor alignment in TDI measurements


Always integrate multiple parameters rather than relying on a single index.



---


Practical Echo Reporting Tips


• Mention diastolic grade explicitly

• Comment on LV filling pressures

• Correlate with symptoms and rhythm

• Avoid overcalling dysfunction in elderly asymptomatic patients



---


Key Point:

Diastology is not a single measurement but a comprehensive integration of Doppler inflow, tissue velocities, atrial size, and clinical context. Mastery of diastolic echo transforms echocardiography from a structural test into a true hemodynamic assessment tool.

Comments

Popular posts from this blog

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB)

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB) Why this differentiation matters Brugada pattern is a malignant channelopathy associated with sudden cardiac death, while incomplete RBBB is usually a benign conduction variant. Mislabeling Brugada as iRBBB can be fatal; overcalling iRBBB as Brugada can lead to unnecessary anxiety and ICD implantation. --- 1. Basic Definitions Brugada ECG Pattern Primary repolarization abnormality Genetic sodium-channel disorder Characteristic ST-segment elevation in V1–V3 Risk of ventricular fibrillation and sudden death Incomplete RBBB (iRBBB) Depolarization abnormality Delay in right ventricular conduction Common in healthy individuals Usually asymptomatic and benign --- 2. ECG Morphology: Side-by-Side Comparison QRS Duration Brugada: QRS usually <120 ms iRBBB: QRS <120 ms, but with RBBB morphology --- V1–V2 Pattern (Key Differentiator) Brugada Pseudo-RBBB appearance ST elevation ≥2 mm ST segment is coved or saddleback Terminal QRS bl...

Acute Treatment of Hyperkalemia

Acute Treatment of Hyperkalemia – A Practical, Bedside-Oriented Guide Hyperkalemia is a potentially life-threatening electrolyte abnormality that demands prompt recognition and decisive management. The danger lies not only in the absolute potassium value but in its effects on cardiac conduction, which can rapidly progress to fatal arrhythmias. Acute treatment focuses on three parallel goals: stabilizing the cardiac membrane, shifting potassium into cells, and removing excess potassium from the body. Understanding this stepwise approach helps clinicians act quickly and rationally in emergency settings. Why Hyperkalemia Is Dangerous Potassium plays a key role in maintaining the resting membrane potential of cardiac myocytes. Elevated serum potassium reduces the transmembrane gradient, leading to slowed conduction, ECG changes, ventricular arrhythmias, and asystole. Importantly, ECG changes do not always correlate with potassium levels, so treatment decisions should be based on clinical c...

π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š

 π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š in  Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts.  The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.